These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9370356)

  • 1. Comparative study in vivo and in vitro of uniformly 14C-labelled and 125I-labelled recombinant fibroblast growth factor 2.
    Colin S; Mascarelli F; Jeanny JC; Vienet R; Bouche G; Courtois Y; Labarre J
    Eur J Biochem; 1997 Oct; 249(2):473-80. PubMed ID: 9370356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo involvement of heparan sulfate proteoglycan in the bioavailability, internalization, and catabolism of exogenous basic fibroblast growth factor.
    Colin S; Jeanny JC; Mascarelli F; Vienet R; Al-Mahmood S; Courtois Y; Labarre J
    Mol Pharmacol; 1999 Jan; 55(1):74-82. PubMed ID: 9882700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the intravenously administered recombinant human basic fibroblast growth factor, trafermin, in liver and kidney: degradation implicated in its selective localization to the fenestrated type microvasculatures.
    Yuge T; Furukawa A; Nakamura K; Nagashima Y; Shinozaki K; Nakamura T; Kimura R
    Biol Pharm Bull; 1997 Jul; 20(7):786-93. PubMed ID: 9255421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition.
    Edelman ER; Nugent MA; Karnovsky MJ
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1513-7. PubMed ID: 8434012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual activities of 22-24 kDA basic fibroblast growth factor: inhibition of migration and stimulation of proliferation.
    Piotrowicz RS; Maher PA; Levin EG
    J Cell Physiol; 1999 Feb; 178(2):144-53. PubMed ID: 10048578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.
    Berry D; Shriver Z; Natke B; Kwan CP; Venkataraman G; Sasisekharan R
    Biochem J; 2003 Jul; 373(Pt 1):241-9. PubMed ID: 12659634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic localization of [125I]-C-ANP compared to [125I]-ANP in rat tissue.
    Heidemann F; Steinke W; Pleiss U; Theiss G; Voges KP; Kazda S; Gerzer R; Stasch JP
    Histochemistry; 1991; 96(4):317-21. PubMed ID: 1838535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative tissue distribution of 125I- and U-14C-labeled recombinant human interleukin-2 in the rat.
    Sabo J; Ni G; Nadeau R; Liberato DJ; Loh A
    Lymphokine Cytokine Res; 1992 Aug; 11(4):229-33. PubMed ID: 1420601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor growth and tumor radiosensitivity in mice given myeloprotective doses of fibroblast growth factors.
    Ding I; Huang K; Snyder ML; Cook J; Zhang L; Wersto N; Okunieff P
    J Natl Cancer Inst; 1996 Oct; 88(19):1399-404. PubMed ID: 8827018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of modulation of basic fibroblast growth factor on tumor growth in vivo.
    Gross JL; Herblin WF; Dusak BA; Czerniak P; Diamond MD; Sun T; Eidsvoog K; Dexter DL; Yayon A
    J Natl Cancer Inst; 1993 Jan; 85(2):121-31. PubMed ID: 8418301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution.
    Laham RJ; Post M; Rezaee M; Donnell-Fink L; Wykrzykowska JJ; Lee SU; Baim DS; Sellke FW
    Drug Metab Dispos; 2005 Aug; 33(8):1101-7. PubMed ID: 15879496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male rats.
    Woodruff TK; Krummen L; Chen SA; Lyon R; Hansen SE; DeGuzman G; Covello R; Mather J; Cossum P
    Endocrinology; 1993 Feb; 132(2):725-34. PubMed ID: 8425491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach.
    Arany E; Zabel P; Hill DJ
    Growth Regul; 1996 Mar; 6(1):32-41. PubMed ID: 8717448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of the recombinant coagulation factor 125I-rFVIIa in rats.
    Beeby TL; Chasseaud LF; Taylor T; Thomsen MK
    Thromb Haemost; 1993 Sep; 70(3):465-8. PubMed ID: 8259550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autoradiographic study of cochlea and organs of guinea pigs after intraperitoneal injection of 125I-labelled bFGF.
    Zhai S; Chen P; Guo W; Yu N; Sun J; Hu Y
    Acta Otolaryngol; 2010 Mar; 130(3):366-9. PubMed ID: 20151873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat.
    Poulsen SS; Thulesen J; Nexø E; Thim L
    Gut; 1998 Aug; 43(2):240-7. PubMed ID: 10189851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo.
    Camozzi M; Zacchigna S; Rusnati M; Coltrini D; Ramirez-Correa G; Bottazzi B; Mantovani A; Giacca M; Presta M
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1837-42. PubMed ID: 16020751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body autoradiographic distribution of exogenously administered renal renin in rats.
    Kim S; Iwao H; Nakamura N; Ikemoto F; Yamamoto K
    J Histochem Cytochem; 1987 May; 35(5):549-57. PubMed ID: 3549890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.